Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model
Please verify you are not a robot.
Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model
Please verify you are not a robot.